Recruiting NA Device Related Thrombosis

New treatment option for Device Related Thrombosis

Official title Direct Comparison of Cardiac CT With TEE to Evaluate Watchman FLX LAA Occluder Device Characteristics

ClinicalTrials.gov ID: NCT06523166

What this study is testing

What it's testing
The current standard of care for patients who underwent left atrial appendage closure (LAAC) is to have follow-up transesophageal echocardiogram (TEE) for device surveillance. TEE is an ultrasound of the heart done by placing a probe in the esophagus under conscious sedation.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • people \>18 years old planned to undergo LAAC
  • eGFR ≥ 30 mL/min per 1.73 m2

You likely can't join if

  • people below the age of 18
  • non-English speaking people
  • eGFR \< 30 mL/min per 1.73 m2
  • people with history of contrast allergy
  • Pregnant women

The study team makes the final eligibility decision.

Where it's taking place

  • Los Angeles, California, United States
  • Roslyn, New York, United States
  • Charlotte, North Carolina, United States
  • Cleveland, Ohio, United States
  • Columbus, Ohio, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Los Angeles, California, United States; Roslyn, New York, United States; Charlotte, North Carolina, United States; Cleveland, Ohio, United States; Columbus, Ohio, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.